Loading clinical trials...
Loading clinical trials...
Background: Cognitive symptoms are common and often severe in patients with brain metastases, significantly impacting their quality of life and ability to manage cancer care. Currently, there is no st...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Health Network, Toronto
NCT07462507 · Central Nervous System Cancer, Brain Metastases
NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more
NCT05987644 · Lung Cancer, NSCLC, and more
NCT05692635 · Brain Metastases, Nonsmall Cell Lung Cancer Stage III
NCT07130786 · Seizures, Primary Motor Cortex, and more
Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions